#53Official Top 100
Baili Pharma
四川百利药业有限责任公司
#53
Oncology, ADC and high-potencyBiologics
Manufacturing profile
Oncology, ADC and high-potency
Biologics
Region: Sichuan
Selection basis
The company is included in the official 2024 ranking of the 100 largest Chinese pharmaceutical-industry enterprises by main-business revenue.
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Representative manufacturing and QC chain
- 1Raw-material receipt and identification
- 2Dispensing, blending and granulation
- 3Tableting, encapsulation or solution preparation
- 4Packaging and labelling
- 5HPLC, GC, KF, ICP/AAS, dissolution and stability QC
- 6Cell bank or microbial seed
- 7Upstream culture or fermentation
- 8Clarification and chromatography
- 9UF/DF, formulation and sterile filtration
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Assay & Impurity HPLC Quality CheckerLC-MS Confirmation Quality CheckerSterility Test Membrane Filtration Quality CheckerBiologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand the scope.
Mapping boundary
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.
Methodology